Literature DB >> 28830848

MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases.

Ailan Cheng1, Lianshu Han, Yun Feng, Huimin Li, Rong Yao, Dengbin Wang, Biao Jin.   

Abstract

PURPOSE: We aimed to evaluate the magnetic resonance imaging (MRI) and clinical features of maple syrup urine disease (MSUD).
METHODS: This retrospective study consisted of 10 MSUD patients confirmed by genetic testing. All patients underwent brain MRI. Phenotype, genotype, and areas of brain injury on MRI were retrospectively reviewed.
RESULTS: Six patients (60%) had the classic form of MSUD with BCKDHB mutation, three patients (30%) had the intermittent form (two with BCKDHA mutations and one with DBT mutation), and one patient (10%) had the thiamine-responsive form with DBT mutation. On diffusion-weighted imaging, nine cases presented restricted diffusion in myelinated areas, and one intermittent case with DBT mutation was normal. The classic form of MSUD involved the basal ganglia in six cases; the cerebellum, mesencephalon, pons, and supratentorial area in five cases; and the thalamus in four cases, respectively. The intermittent form involved the cerebellum, pons, and supratentorial area in two cases. The thiamine-responsive form involved the basal ganglia and supratentorial area.
CONCLUSION: Our preliminary results indicate that patients with MSUD presented more commonly in classic form with BCKDHB mutation and displayed extensive brain injury on MRI.

Entities:  

Mesh:

Year:  2017        PMID: 28830848      PMCID: PMC5602367          DOI: 10.5152/dir.2017.16466

Source DB:  PubMed          Journal:  Diagn Interv Radiol        ISSN: 1305-3825            Impact factor:   2.630


  21 in total

1.  Analysis of gene mutations in Chinese patients with maple syrup urine disease.

Authors:  Nan Yang; Lianshu Han; Xuefan Gu; Jun Ye; Wenjuan Qiu; Huiwen Zhang; Zhuwen Gong; Yafen Zhang
Journal:  Mol Genet Metab       Date:  2012-06-06       Impact factor: 4.797

2.  Contribution of the diffusion-weighted MRI in the diagnosis and follow-up of encephalopathy caused by maple syrup urine disease in a full-term newborn.

Authors:  José Roberto Lopes Ferraz-Filho; Valdeci Hélio Floriano; Marcelo Bianco Quirici; Regina Pires de Albuquerque; Antônio Soares Souza
Journal:  Arq Neuropsiquiatr       Date:  2009-09       Impact factor: 1.420

3.  Cerebral edema in maple syrup urine disease despite newborn screening diagnosis and early initiation of treatment.

Authors:  Kenneth A Myers; Melanie Reeves; Xing-Chang Wei; Aneal Khan
Journal:  JIMD Rep       Date:  2011-09-22

4.  Diffusion-weighted magnetic resonance imaging in a case of severe classic maple syrup urine disease.

Authors:  Wei Xia; Wenzhong Yang
Journal:  J Pediatr Endocrinol Metab       Date:  2015-07       Impact factor: 1.634

5.  Maple syrup urine disease: diffusion-weighted MRI findings during acute metabolic encephalopathic crisis.

Authors:  Rukiye Kilicarslan; Alpay Alkan; Demet Demirkol; Huseyin Toprak; Rasul Sharifov
Journal:  Jpn J Radiol       Date:  2012-04-03       Impact factor: 2.374

6.  Maple syrup urine disease: findings on CT and MR scans of the brain in 10 infants.

Authors:  J Brismar; A Aqeel; G Brismar; R Coates; G Gascon; P Ozand
Journal:  AJNR Am J Neuroradiol       Date:  1990 Nov-Dec       Impact factor: 3.825

7.  Diagnosis and treatment of maple syrup disease: a study of 36 patients.

Authors:  D Holmes Morton; Kevin A Strauss; Donna L Robinson; Erik G Puffenberger; Richard I Kelley
Journal:  Pediatrics       Date:  2002-06       Impact factor: 7.124

8.  Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease.

Authors:  S Schönberger; B Schweiger; B Schwahn; M Schwarz; U Wendel
Journal:  Mol Genet Metab       Date:  2004-05       Impact factor: 4.797

9.  Classical maple syrup urine disease and brain development: principles of management and formula design.

Authors:  Kevin A Strauss; Bridget Wardley; Donna Robinson; Christine Hendrickson; Nicholas L Rider; Erik G Puffenberger; Diana Shellmer; Diana Shelmer; Ann B Moser; D Holmes Morton
Journal:  Mol Genet Metab       Date:  2010-01-12       Impact factor: 4.797

10.  Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease.

Authors:  William J Zinnanti; Jelena Lazovic; Kathleen Griffin; Kristen J Skvorak; Harbhajan S Paul; Gregg E Homanics; Maria C Bewley; Keith C Cheng; Kathryn F Lanoue; John M Flanagan
Journal:  Brain       Date:  2009-03-17       Impact factor: 13.501

View more
  4 in total

1.  The clinico-radiological findings of MSUD in a group of Egyptian children: Contribution to early diagnosis and outcome.

Authors:  Montaser M Mohamed; Mohamed A Bakheet; Rofaida M Magdy; Heba S El-Abd; Mohamad Hasan Alam-Eldeen; Hany M Abo-Haded
Journal:  Mol Genet Genomic Med       Date:  2021-08-25       Impact factor: 2.183

2.  A Novel Whole Gene Deletion of BCKDHB by Alu-Mediated Non-allelic Recombination in a Chinese Patient With Maple Syrup Urine Disease.

Authors:  Gang Liu; Dingyuan Ma; Ping Hu; Wen Wang; Chunyu Luo; Yan Wang; Yun Sun; Jingjing Zhang; Tao Jiang; Zhengfeng Xu
Journal:  Front Genet       Date:  2018-04-24       Impact factor: 4.599

3.  Case report: maple syrup urine disease with a novel DBT gene mutation.

Authors:  Wei Feng; Jinfu Jia; Heyang Guan; Qing Tian
Journal:  BMC Pediatr       Date:  2019-12-13       Impact factor: 2.125

Review 4.  Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders.

Authors:  Jing Xu; Youseff Jakher; Rebecca C Ahrens-Nicklas
Journal:  Int J Mol Sci       Date:  2020-10-11       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.